Acquired immunity in nude mice induced by expression of the IL-2 or IL- 4 gene in human pancreatic carcinoma cells and anti-tumor effect generated by in vivo gene transfer using retrovirus

International Journal of Cancer

Volumn 82, Issue 4, 1999, Pages 549-555

  Kimura, Masaki ^a,b   Yoshida, Yu ^a,b   Narita, Mitsuro ^a,b   Takenaga, Keizo ^a   Takenouchi, Toshinao ^a   Yamaguchi, Taketo ^b   Saisho, Hiromitsu ^b   Sakiyama, Shigeru ^a   Tagawa, Masatoshi ^a  

^a CHIBA CANCER CENTER   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CELL INFILTRATION; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINE PRODUCTION; GENE EXPRESSION; GENE TRANSFER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS CARCINOMA; PRIORITY JOURNAL; RETROVIRUS;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENE TRANSFER TECHNIQUES; GRAFT REJECTION; HUMANS; INTERLEUKIN-2; INTERLEUKIN-4; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICE, NUDE; MICE, SCID; PANCREATIC NEOPLASMS; PERITONEAL CAVITY; RETROVIRIDAE; TUMOR CELLS, CULTURED;

EID: 0032817103     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990812)82:4<549::AID-IJC13>3.0.CO;2-0     Document Type: Article

References (29)

1. ARIENTI, E., SULÉ-SUSO, J., MELANI, C., MACCALLI, C., BELLI, F., ILLENI, M.T., ANICHINI, A., CASCINELLI, N., COLOMBO, M.P. and PARMIANI, G., Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes. Hum. Gene Ther., 5, 1139-1150 (1994).
2. ARTEAGA, C.L. and HOLT, J.T., Tissue-targeted antisense c-fos retroviral vector inhibits established breast cancer xenografts in nude mice. Cancer Res., 56, 1098-1103 (1996).
3. BENDELAC, A., RIVERA, M.N., PARK, S.-H. and ROARK, J.H., Mouse CD1-specific NK1 T cells: development, specificity, and function. Ann. Rev. Immunol., 15, 535-562 (1997).
4. CHEN, W.H., HOROSZEWICZ, J.S., LEONG, S.S., SHIMANO, T., PENETRANTE, R., SANDERS, W.H., BERJIAN, R., DOUGLASS, H.O., MARTIN, E.W. and CHU, T.M., Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites. In Vitro, 18, 24-34 (1982).
5. CLARY, B.M., COVENEY, E.C., BLAZER III, D.G., PHILIP, R. and LYERLY, H.K., Active immunotherapy of pancreatic cancer with tumor cells genetically engineered to secrete multiple cytokines. Surgery, 120, 178-181 (1996).
6. CLARY, B.M., COVENEY, E.C., PHILIP, R., BLAZER III, D.G., MORSE, M., GILBOA, E. and LYERLY, H.K., Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells. Cancer Gene Ther., 4, 97-104 (1997).
7. DRANOFF, G., JAFFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D. and MULLIGAN, R.C., Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. nat. Acad. Sci. (Wash.), 90, 3539-3543 (1993).
8. FARRELL, H.E., VALLY, H., LYNCH, D.M., FLEMING, P., SHELLAM, G.R., SCALZO, A.A. and DAVIS-POYNTER, N.J., Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature (Lond.), 386, 510-514 (1997).
9. FERRICK, D.A., OHASHI, P.S., WALLACE, V., SCHILHAM, M. and MAK, T.W., Thymic ontogeny and selection of αβ and γ/δ T cells. Immunol. Today, 10, 403-407 (1989).
10. HOLT, J.T., THOMPSON, M.E., SZABO, C., ROBINSON-BENION, C., ARTEAGA, C.L., KING, M.-C. and JENSEN, R.A., Growth retardation and tumour inhibition by BRCA1. Nature (Genet.), 12, 298-302 (1996).
11. HURFORD, R.K., JR., DRANOFF, G., MULLIGAN, R.C. and TEPPER, R.I., Gene therapy of metastatic cancer by in vivo retroviral gene targeting. Nature (Genet.), 10, 430-435 (1995).
12. KENNEDY, J.D., PIERCE, C.W. and LAKE, J.P., Extrathymic T cell maturation. Phenotypic analysis of T cell subsets in nude mice as a function of age. J. Immunol., 148, 1620-1629 (1992).
13. KIMURA, M., TAGAWA, M., YOSHIDA, Y., TAKENOUCHI, T., TAKENAGA, K., AZUMA, K., YAMAGUCHI, T., SAISHO, H. and SAKIYAMA, S., Impaired in vivo tumor growth of human pancreatic carcinoma cells retrovirally transduced with GM-CSF gene. Anticancer Res., 18, 165-170 (1998).
14. LI, Y, NEWBY, S.A., JOHNSTON, J.V., HELLSTRM, K.E. and CHEN, L., Protective immunity induced by B7/CD28-costimulated γδ T cells to the EL-4 lymphoma in allogenic athymic mice. J. Immunol., 155, 5705-5710 (1995).
15. MILLER, A.D. and ROSMAN, G.J., Improved retroviral vectors for gene transfer and expression. BioTechniques, 7, 980-990 (1989).
16. OTUJI, M., KIMURA, Y., AOE, T., OKAMOTO, Y. and SAITO, T., Oxidative stress by tumor-derived macrophages suppresses the expression of CD3??chain of T-cell receptor complex and antigen-specific T-cell responses. Proc. nat. Acad. Sci. (Wash.), 93, 13119-13124 (1996).
17. PEPLINSKI, G.R., TSUNG, K., MEKO, J.B. and NORTON, J.A., In vivo gene therapy of a murine pancreas tumor with recombinant vaccinia virus encoding human interleukin-1 beta. Surgery, 118, 185-191 (1995).
18. RESTIFO, N.P., ESQUIVEL, F., KAWAKAMI, Y., YEWDELL, J.W., MUL, J.J., ROSENBERG, S.A. and BENMINK, J.R., Identification of human cancers deficient in antigen processing. J. exp. Med., 177, 265-272 (1993).
19. ROTH, J.A. and CRISTIANO, R.J., Gene therapy for cancer: what have we done and where are we going? J. nat. Cancer Inst., 88, 21-39 (1997).
20. RUSSELL, D.W., BERGER, M.S. and MILLER, A.D., The effects of human serum and cerebrospinal fluid on retroviral vectors and packaging cell lines. Hum. Gene Ther., 6, 635-641 (1995).
21. SHERWIN, S.A., BENVENISTE, R.E. and TODARO, G.J., Complement-mediated lysis of type-C virus: effect of primate and human sera on various retroviruses. Int. J. Cancer, 21, 6-11 (1978).
22. TEPPER, R.I. and MULÉ, J.J., Experimental and clinical studies of cytokine gene-modified tumor cells. Hum. Gene Ther., 5, 153-164 (1994).
23. WARSHAW, A.L. and FERNNDES-DEL CASTILLO, C., Pancreatic carcinoma. N. Engl. J. Med., 326, 455-465 (1992).
24. WELSH, R.M., JR., COOPER, N.R., JENSEN, F.C. and OLDSTONE, M.B.A., Human serum lyses RNA tumour viruses. Nature (Lond.), 257, 612-614 (1975).
25. WOJTOWICZ-PRAGA, S., Reversal of tumor-induced immunosuppression: a new approach to cancer therapy. J. Immunol., 20, 165-177 (1997).
26. YAMADA, G., KITAMURA, Y., SONODA, H., HARADA, H., TAKI, S., MULLIGAN, R.C., OSAWA, H., DIAMANTSTEIN, T., YOKOYAMA, S. and TANIGUCHI, T., Retroviral expression of the human IL-2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity. EMBO J., 6, 2705-2709 (1987).
27. YANG, L., HWANG, R., PANDIT, L., GORDON, E.M., ANDERSON, W.A. and PAREKH, D., Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir. Ann. Surg., 224, 405-417 (1996).
28. YOKOTA, T., OTSUKA, T., MOSMANN, T., BANCHEREAU, J., DEFRANCE, T., BLANCHARD, D., DE VRIES, J.E., LEE, F. and ARAI, K., Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities. Proc. nat. Acad. Sci. (Wash), 83, 2061-2065 (1986).
29. Yu, J.S., WEI, M.X., CHIOCCA, E.A., MARTUZA, R.L. and TEPPER, R.I., Treatment of glioma by engineered interleukin 4-secreting cells. Cancer Res., 53, 3125-3128 (1993).